Lemtrada shows promising results for RRMS patients
Lemtrada shows promising results for RRMS patients
Two clinical trials investigating the long-term effects of Lemtrada (alemtuzmab) in multiple sclerosis (MS) patients has revealed that the drug maintained outcomes, even in the absence of further treatment...Read more - http://www.ms-uk.org/lemtrada-shows-pro ... nts-280217
MS-UK - http://www.ms-uk.org/